| Project/Area Number |
16H06756
|
|---|
| Research Category |
Grant-in-Aid for Research Activity Start-up
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Radiation science
|
|---|
| Research Institution | The University of Tokyo |
|---|
Principal Investigator |
Ogita Mami 東京大学, 医学部附属病院, 助教 (60779784)
|
|---|
| Project Period (FY) |
2016-08-26 – 2018-03-31
|
| Project Status |
Completed (Fiscal Year 2017)
|
| Budget Amount *help |
¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000)
Fiscal Year 2017: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
|---|
| Keywords | 前立腺癌 / 定位放射線治療 / ハイドロゲルスペーサー / 放射線 |
|---|
| Outline of Final Research Achievements |
Rectal toxicities are major concerns in radiotherapy for prostate cancer. We conducted this phase II clinical trial to evaluate the safety and the efficacy of stereotactic body radiotherapy (SBRT) for prostate cancer with the use of hydrogel spacers, which may reduce rectal toxicities by pushing the rectum away from the prostate. This is the first study using the hydrogel spacers in Japanese population, and we found the hydrogel spacers can be safely applied to Japanese prostate cancer patients. As there have been few reports of the hydrogel spacers in SBRT, our study provided important data. We will continue to follow up the study participants, and evaluate the safety and the efficacy of the hydrogel spacers in SBRT in prostate cancer patients.
|
